Suppr超能文献

2001年1型疫苗衍生脊髓灰质炎病毒在菲律宾的传播情况。

Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

作者信息

Shimizu Hiroyuki, Thorley Bruce, Paladin Fem Julia, Brussen Kerri Anne, Stambos Vicki, Yuen Lilly, Utama Andi, Tano Yoshio, Arita Minetaro, Yoshida Hiromu, Yoneyama Tetsuo, Benegas Agnes, Roesel Sigrun, Pallansch Mark, Kew Olen, Miyamura Tatsuo

机构信息

Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.

出版信息

J Virol. 2004 Dec;78(24):13512-21. doi: 10.1128/JVI.78.24.13512-13521.2004.

Abstract

In 2001, highly evolved type 1 circulating vaccine-derived poliovirus (cVDPV) was isolated from three acute flaccid paralysis patients and one contact from three separate communities in the Philippines. Complete genomic sequencing of these four cVDPV isolates revealed that the capsid region was derived from the Sabin 1 vaccine strain but most of the noncapsid region was derived from an unidentified enterovirus unrelated to the oral poliovirus vaccine (OPV) strains. The sequences of the cVDPV isolates were closely related to each other, and the isolates had a common recombination site. Most of the genetic and biological properties of the cVDPV isolates were indistinguishable from those of wild polioviruses. However, the most recently identified cVDPV isolate from a healthy contact retained the temperature sensitivity and partial attenuation phenotypes. The sequence relationships among the isolates and Sabin 1 suggested that cVDPV originated from an OPV dose given in 1998 to 1999 and that cVDPV circulated along a narrow chain of transmission. Type 1 cVDPV was last detected in the Philippines in September 2001, and population immunity to polio was raised by extensive OPV campaigns in late 2001 and early 2002.

摘要

2001年,在菲律宾三个不同社区的三名急性弛缓性麻痹患者及一名接触者中分离出高度进化的1型循环疫苗衍生脊髓灰质炎病毒(cVDPV)。对这四株cVDPV分离株进行全基因组测序发现,衣壳区域源自Sabin 1疫苗株,但大部分非衣壳区域源自一种与口服脊髓灰质炎疫苗(OPV)株无关的未鉴定肠道病毒。这些cVDPV分离株的序列彼此密切相关,且分离株具有一个共同的重组位点。cVDPV分离株的大多数遗传和生物学特性与野生脊髓灰质炎病毒无法区分。然而,最近从一名健康接触者中鉴定出的cVDPV分离株保留了温度敏感性和部分减毒表型。分离株与Sabin 1之间的序列关系表明,cVDPV起源于1998年至1999年接种的一剂OPV,且cVDPV沿着一条狭窄的传播链传播。2001年9月在菲律宾最后一次检测到1型cVDPV,2001年末和2002年初通过广泛的OPV接种活动提高了人群对脊髓灰质炎的免疫力。

相似文献

1
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.
J Virol. 2004 Dec;78(24):13512-21. doi: 10.1128/JVI.78.24.13512-13521.2004.
2
Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
J Virol. 2015 Oct 14;90(1):317-31. doi: 10.1128/JVI.01532-15. Print 2016 Jan 1.
4
Circulating vaccine-derived polioviruses: current state of knowledge.
Bull World Health Organ. 2004 Jan;82(1):16-23. Epub 2004 Feb 26.
5
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.
J Virol. 2003 Aug;77(15):8366-77. doi: 10.1128/jvi.77.15.8366-8377.2003.
8
Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece.
Appl Environ Microbiol. 2007 Nov;73(21):6697-704. doi: 10.1128/AEM.00535-07. Epub 2007 Sep 7.
9
Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
J Appl Microbiol. 2006 Dec;101(6):1367-79. doi: 10.1111/j.1365-2672.2006.03020.x.
10
Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China.
J Clin Microbiol. 2010 Sep;48(9):3274-80. doi: 10.1128/JCM.00712-10. Epub 2010 Jul 14.

引用本文的文献

1
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions.
Vaccines (Basel). 2024 Nov 28;12(12):1345. doi: 10.3390/vaccines12121345.
3
Outbreak Response to Circulating Vaccine-Derived Poliovirus in Three Northern Regions of Ghana, 2019.
Biomed Res Int. 2024 Oct 4;2024:5515777. doi: 10.1155/2024/5515777. eCollection 2024.
4
Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?
Front Public Health. 2024 Jan 8;11:1284337. doi: 10.3389/fpubh.2023.1284337. eCollection 2023.
5
Genetic characterization and molecular evolution of type 3 vaccine-derived polioviruses from an immunodeficient patient in China.
Virus Res. 2023 Sep;334:199177. doi: 10.1016/j.virusres.2023.199177. Epub 2023 Jul 24.
6
The Fight against Poliovirus Is Not Over.
Microorganisms. 2023 May 17;11(5):1323. doi: 10.3390/microorganisms11051323.
7
10
Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients.
Vaccine. 2020 Mar 23;38(14):3042-3049. doi: 10.1016/j.vaccine.2020.02.035. Epub 2020 Feb 20.

本文引用的文献

1
Circulating vaccine-derived polioviruses: current state of knowledge.
Bull World Health Organ. 2004 Jan;82(1):16-23. Epub 2004 Feb 26.
4
Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.
J Virol. 2003 Oct;77(20):10994-1005. doi: 10.1128/jvi.77.20.10994-11005.2003.
6
Importation and circulation of poliovirus in Bulgaria in 2001.
Bull World Health Organ. 2003;81(7):476-81. Epub 2003 Sep 3.
7
Recombination in circulating enteroviruses.
J Virol. 2003 Oct;77(19):10423-31. doi: 10.1128/jvi.77.19.10423-10431.2003.
8
Polio eradication: the OPV paradox.
Rev Med Virol. 2003 Sep-Oct;13(5):277-91. doi: 10.1002/rmv.401.
9
Recombinant vaccine-derived poliovirus in Madagascar.
Emerg Infect Dis. 2003 Jul;9(7):885-7. doi: 10.3201/eid0907.020692.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验